Navigation Links
IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service
Date:10/3/2007

Former Procter & Gamble security executive has agreed to work with

IntegriChain to enhance the company's Market Vigilance(TM) Survey

Program(TM).

PRINCETON, N.J., Oct. 3 /PRNewswire/ -- IntegriChain, Inc. the leading provider of analytic services to maximize channel integrity and create business value for pharmaceutical, biotech, and medical device companies, today announces the agreement with Ed Casey and Associates to manage their Market Vigilance Survey Program(TM). Mr. Casey brings a depth of pharmaceutical domain expertise, corporate security and law enforcement leadership experience spanning more than 34 years.

Mr. Casey retired as the Director of Global Security for the Procter & Gamble Company after a 20 year career. Prior to P&G, he served for 14 years as a Special Agent with the U.S. Treasury Department where he concentrated on white-collar crime investigations. Mr. Casey holds memberships in a variety of security organizations including; American Society for Industrial Security (ASIS), International Security Management Association (ISMA) and the Chief Security Officers Executive Council's Board of Advisors of which he is a founding member.

Market Vigilance Survey Program utilizes IntegriChain's channel analytics capabilities to identify possible U.S. outlets including hospitals, clinics, long term care facilities and other NGOs that are possibly diverting or facilitating the movement of counterfeit product in the U.S. supply chain. Once identified as an at-risk outlet, the Survey Program can solicit and purchase product to ensure the efficacy of the product provided. IntegriChain's service has been used successfully by several large pharmaceutical manufacturers to identify and purchase illegal or illicit product from a host of U.S. wholesalers, long term care facilities, hospitals, retail outlets and other NGOs.

"The integrity of the pharmaceutical value chain is being challenged every day. The IntegriChain solutions are well positioned to identify and quantify the level of risk for our customers," said Casey. "I'm pleased to work with IntegriChain team to deliver high-value solutions for the industry."

"IntegriChain is working with 11 of the top 20 U.S. pharmaceutical manufacturers across a broad range of channel integrity analytics, including 'safe and secure' initiatives, demand data validation, and EDI data integration and quality assurance," states Kevin Leininger, chief executive officer of IntegriChain. "We are excited to welcome Ed and look forward to his experience, leadership and acceleration of this valuable service to the pharmaceutical industry."

About IntegriChain, Inc.

IntegriChain is the premier provider of supply chain visibility and integrity solutions to the healthcare industry. Leading manufacturers employ IntegriChain's proprietary data enrichment and analytic services to increase supply chain transparency and accountability. Managed markets, sales operations, supply chain and product protection managers leverage IntegriChain to reduce diversion and importation, prevent stock-outs, and maximize sales and marketing responsiveness throughout the product life cycle. Manufacturers utilize IntegriChain to monitor more than $35 billion of pharmaceutical trade, achieving measurable returns in added revenue and enhanced brand integrity. For more information visit the company's website at http://www.integrichain.com


'/>"/>
SOURCE IntegriChain, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Supercomputer Grid Enlists PCs To Combat AIDS
2. Nova Scotia MP, Bill Casey, indebted to Cadman clinic
3. A Carrier Protein Associates With Human Insulin Resistance
4. Sleepy drivers increase road death toll
5. Traffic Violations Result in Safer Drivers
6. Dyslexia may slow a drivers reaction time as much as moderate drinking!!
7. Study suggests symptom driven therapy for adults with asthma
8. Peppermint or cinnamon smell can make drivers more alert
9. Mechanical forces drive early heart development
10. Measles Vaccination Drive Intensified In Quake-Hit Pakistan
11. More Funds Are Required For Immunisation Drive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
Breaking Medicine Technology: